BDA Partners among top advisors, as Korean M&A rebounds

Korea’s M&A market showed encouraging signs of recovery during 3Q24, with optimism surrounding potential interest rate cuts and restructuring efforts from large conglomerates driving increased deal activity. PE funds aggressively pursued M&A opportunities, which led to a notable rise in high-value transactions. Five deals exceeded KRW1 trillion (US$750m) in 3Q24, compared to just one in 1H24.

Among the highest profile transactions during this period was the KRW2 trillion (US$1.5b) acquisition of Ecorbit, underscoring Korea’s active deal environment. BDA Partners played a key role in the transaction, advising the buyer, IMM Consortium, working across the table from UBS and Citi. This involvement has led BDA Partners to secure its place near the top of the M&A league tables for corporate acquisitions with a total transaction value of KRW 2.07 trillion in 3Q24.

This surge in large-scale deals reflects growing confidence in the market, as both local and international players capitalise on the improving financial advisory landscape. With interest rates expected to decline, even more M&A opportunities are likely to emerge, particularly in sectors such as waste management and semiconductors. BDA Partners, with its extensive experience, is well-positioned to navigate high-value transactions, as the market outlook remains positive.

Read the original article here

Many global multinationals are divesting their Chinese assets because of geopolitical tensions.

BDA Partners has developed expertise in finding buyers, often local Chinese financial sponsors or corporates, to acquire these assets.

If you are considering divesting anything in China, please speak with us to learn what options may be possible.

Here are some examples of Chinese divestitures we have managed:

China MNC Divestitures Credentials

The global fertility services market is expected to grow at a robust CAGR of 7% over the next decade, driven by an aging global population, rising infertility rates, and couples delaying childbirth. Market demand tailwinds are even more pronounced in Asia and the fertility market ecosystem is relatively nascent compared to the West. Asia Pacific market is expected to grow at a CAGR of 10% over the next 10-years, significantly outpacing global growth. Scaled regional players have started to emerge and are looking to consolidate the highly fragmented market, taking advantage of scale economies, leveraging regulatory differences across markets, sharing of best practices, clinic expertise and technology to drive better patient outcomes / success rates.

The fertility services market has attracted significant interest from both strategic and financial investors seeking to build regional platforms:

In the next five years, we expect significant M&A activity in the fertility services sector across Asia, with a particular acceleration in SEA and India as several large players establish their dominant positions in the region.

Please reach out to BDA Partners for a discussion regarding specific IVF M&A / investment opportunities.

Download the full report for more insights regarding the IVF sector landscape in Asia.

Since the start of 2024, we have seen a strong upturn in M&A after a challenging year. BDA’s pipeline and sector expertise have continued to grow. We have published many insight pieces from our sector heads within Consumer & Retail, Health and Technology this year. Please join our mailing list to read our latest insights and reach out to BDA Partners for a discussion regarding specific M&A opportunities. 

The beauty sector is glowing and glowing in Asia

North Asian countries already comprise the world’s largest markets for beauty and personal care products. China, Korea and Japan together represent 35% of the global market, with above average growth. China skyrocketed to become the industry leader in this region, but has witnessed a troubling market hangover in the last 12 months.

Read more

Asia GP-led secondaries: A new normal for liquidity? 

GP-led secondaries have become a more attractive, alternative, path to liquidity amid a challenging exit environment for sponsors during the past two years. While APAC markets still lag behind their Western counterparts in utilising this type of transaction, recent completed transactions have been encouraging.

Read more

Say hello to the new Maharajahs: India is the new luxury hub

For a decade, China has been the engine for global luxury growth. China now accounts for 25% of global luxury spending, but this year, China’s growth has slowed to a trickle.

India today is a much smaller luxury market, representing 5% of global luxury spend, but it’s suddenly seeing explosive growth.

GDP growth, 8.2% in 2023, lit the touch paper. Next: the fireworks.

Read more

Software in Asia

Underpinned by continued digitalisation, rapid adoption of localised, cloud-native mission-critical Software, attractive demographics and other market tailwinds, Asian Software is set to outpace Global Software growth, reaching ~20% share of the Global Software market by 2028.

In our latest insight piece, we summarise our key observations on the Asian Software landscape.

Read more

China Healthcare M&A outlook for 2024

In China’s dynamic healthcare market, M&A activities are booming due to an ageing population and increasing consumer health demands. The sector is seeing heavy domestic investments from Chinese firms and Government funds.

In our latest Insights piece, we summarise the predicted outlook of China healthcare M&A for 2024.

Read more

HealthTech sector landscape 
 

The HealthTech industry has seen substantial expansion in recent years, largely propelled by the widespread acceptance of digital healthcare services. 

In this Insights piece, we summarise the global HealthTech sector landscape.

Read more

North Asian countries already comprise the world’s largest markets for beauty and personal care products. China, Korea and Japan together represent 35% of the global market, with above average growth. China skyrocketed to become the industry leader in this region, but has witnessed a troubling market hangover in the last 12 months.

Asia Pacific’s luxury beauty segment – especially China – face the challenge of justifying high prices to increasingly sophisticated and discerning consumers, against a backdrop of economic uncertainty and rising quality and quantity of brands at more accessible price points. At the same time, younger women – and men – are spending more each year.

North America makes up 25% of the global market, while Europe makes up 20%. And those regions are increasingly looking to Asia for innovation and growth.

Asian beauty brands have recovered from the pandemic, and are jostling to find new, compelling ways to connect with consumers. Beauty influencers and DTC brands are both driving and adapting to buyer preferences.

In the past, people would buy beauty brands landed in China purely because they were ‘Made in France’ or ‘Made in Switzerland’. Suddenly now, Asian consumers are rediscovering and appreciating their own rich cultural backgrounds and ancient beauty practices.

This swelling national pride has encouraged new Chinese domestic labels to engage in premium-isation, to offer more interesting propositions, drawing on home advantage. Compared to international peers, they have innovated faster and shown themselves to be adaptable and responsive to local consumer trends. International brands are finding it increasingly hard to grow market share, unless they speak to local preferences.

L’Oréal remains the leading global beauty products company, with US$40bn in global sales, double the size of second-place Unilever. Rounding out the top five are Estée Lauder, P&G and the Japanese giant: Shiseido. All of these are fighting to find growth across Asia, although Estée’s big bets on China have mostly misfired.

Once the domain of Western beauty leaders, the cosmetics industry across Asia is now booming, at least outside China, blending Eastern and Western elements. Rising disposable income and evolving lifestyles drive this growth, marking the beauty industry as one of the most radiant and lucrative consumer segments.

BDA’s latest Insight report shows that:

Younger emerging Western beauty leaders such as Kylie Cosmetics and Fenty Beauty are debuting in India, China and SE Asia to widen their consumer base.

The market is evolving and shifting fast. BDA is carefully monitoring these market dynamics, working on multiple transactions in the space. We’ve closed a number of exciting beauty transactions. We’re seeing strong dealflow. Let us know if we can help you.

GP-led secondaries have become a more attractive, alternative, path to liquidity amid a challenging exit environment for sponsors during the past two years. While APAC markets still lag behind their Western counterparts in terms of utilising this type of transaction, recent completed transactions have been encouraging.

In BDA’s latest insight piece, we share our key thoughts on the Asian GP-Led secondaries landscape:

Download the full report for more insights on the Asian GP-led secondaries

For a decade, China has been the engine for global luxury growth. China now accounts for 25% of global luxury spending, but this year, China’s growth has slowed to a trickle.

India today is a much smaller luxury market, representing 5% of global luxury spend, but it’s suddenly seeing explosive growth.

GDP growth, 8.2% in 2023, lit the touch paper. Next: the fireworks.

India is the fastest-growing major global economy. Political reform and a fast-growing, hyper-aspirational, young middle-class are driving India toward being the third largest consumer market globally.

The luxury and ultra-luxury sectors, across real estate, hospitality, apparel, accessories and automotive, are witnessing phenomenal growth. In BDA’s latest insight piece, we analyse the tremendous growth of luxury in India.

Download the full report for more insights on the luxury sector in India


About BDA Partners

BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 25 years’ experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Mumbai, Singapore, Ho Chi Minh City, Hong Kong, Shanghai, Seoul and Tokyo. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services, Sustainability and Technology sectors. We work relentlessly to earn our clients’ trust by delivering insightful advice and outstanding outcomes.

BDA Partners has strategic partnerships with William Blair, a premier global investment banking business, and with DBJ (Development Bank of Japan), a Japanese Government-owned bank with US$150bn of assets.

US securities transactions are performed by BDA Partners’ affiliate, BDA Advisors Inc, a broker-dealer registered with the Securities and Exchange Commission (SEC). BDA Advisors Inc is a member of the Financial Industry Regulatory Authority (FINRA) and SIPC. In the UK, BDA Partners is authorized and regulated by the Financial Conduct Authority (FCA). In Hong Kong, BDA Partners (HK) Ltd is licensed and regulated by the Securities & Futures Commission (SFC) to conduct Type 1 and Type 4 regulated activities to professional investors. www.bdapartners.com  

Underpinned by continued digitalisation, rapid adoption of localised, cloud-native mission-critical Software, attractive demographics and other market tailwinds, Asian Software is set to outpace Global Software growth, reaching ~20% share of the Global Software market by 2028.

In our latest insight piece, we summarise our key observations on the Asian Software landscape:

Download the full report for more insights regarding Software in Asia. 

In China’s dynamic healthcare market, M&A activities are booming due to an ageing population and increasing consumer health demands. The sector is seeing heavy domestic investments from Chinese firms and Government funds. PE firms are seizing M&A opportunities amid capital raising challenges. Chinese companies are also eyeing cross-border M&A for tech-driven healthcare targets. The market outlook indicates industry reshuffles, rising demands for elderly care and consumer health, and flexible growth strategies by multinational firms.

Investment trends highlight a focus on resilient segments, surging investment in out-of-pocket payment sectors and Chinese firms expanding globally, particularly across SE Asia and the Middle East. European healthcare companies remain attractive for Chinese investors; licensing deals are on the rise, led by Chinese pharma firms. 

In our latest Insights piece, we summarise the predicted outlook of China healthcare M&A for 2024:

Download the full report for more Insights regarding the Chinese healthcare sector.


About BDA Partners

BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 25 years’ experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Mumbai, Singapore, Ho Chi Minh City, Hong Kong, Shanghai, Seoul, and Tokyo. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services, Sustainability and Technology sectors. We work relentlessly to earn our clients’ trust by delivering insightful advice and outstanding outcomes.

BDA Partners has strategic partnerships with William Blair, a premier global investment banking business, and with DBJ (Development Bank of Japan), a Japanese Government-owned bank with US$150bn of assets. bdapartners.com

The HealthTech industry has seen substantial expansion in recent years, largely propelled by the widespread acceptance of digital healthcare services. The COVID-19 pandemic has brought about a shift in people’s attitudes, resulting in increased confidence in virtual healthcare delivery and a noticeable increase in participation by service providers, a trend that has been historically low. In our latest insight piece, we summarise the global HealthTech sector landscape.

Download the full report for more insights regarding the global HealthTech sector landscape


About BDA Partners

BDA Partners is the global investment banking advisor for Asia. We are a premium provider of Asia-related advice to sophisticated clients globally, with over 25 years’ experience advising on cross-border M&A, capital raising, and financial restructuring. We provide global reach with our teams in New York and London, and true regional depth through our seven Asian offices in Mumbai, Singapore, Ho Chi Minh City, Hong Kong, Shanghai, Seoul, and Tokyo. BDA has deep expertise in the Chemicals, Consumer & Retail, Health, Industrials, Services, Sustainability and Technology sectors. We work relentlessly to earn our clients’ trust by delivering insightful advice and outstanding outcomes.

BDA Partners has strategic partnerships with William Blair, a premier global investment banking business, and with DBJ (Development Bank of Japan), a Japanese Government-owned bank with US$150bn of assets. bdapartners.com